150256-42-1

Basic information

• Product Name: FMOC-2-AMINOBENZOIC ACID
• Synonyms: N-[(9H-Fluoren-9-ylmethoxy)carbonyl]anthranilic Acid;Fmoc-2-aminobenzoic acid≥ 98% (HPLC);RARECHEM EM WB 0011;N-2-(9-FLUORENYLMETHYLOXYCARBONYL)AMINO-BENZOIC ACID;N-FMOC-ANTHRANILIC ACID;N-(9-FLUORENYLMETHOXYCARBONYL)ANTHRANILIC ACID;N-ALPHA-FMOC-2-AMINOBENZOIC ACID;FMOC-ABZ-OH
• CAS NO: 150256-42-1
• Molecular Formula: C₂₂H₁₇NO₄
• Molecular Weight: 359.37
• Product Categories: FMOC;Miscellaneous Amino Acids;Amino Acids;Unusual Amino Acids;Amino Acid Derivatives
• Mol File: 150256-42-1.mol

Chemical Properties

• Melting Point: 216-218 °C(lit.)
• Boiling Point: 537.6 °C at 760 mmHg
• Flash Point: 278.9 °C
• Appearance: White to off-white/Powder
• Density: g/cm³
• Vapor Pressure: 2.17E-12mmHg at 25°C
• Storage Temp.: 2-8°C
• Solubility: soluble in Dimethylformamide
• PKA: 3.60±0.36(Predicted)
• Water Solubility: Soluble in water or 1% acetic acid.
• BRN: 7659726
• CAS DataBase Reference: FMOC-2-AMINOBENZOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: FMOC-2-AMINOBENZOIC ACID(150256-42-1)
• EPA Substance Registry System: FMOC-2-AMINOBENZOIC ACID(150256-42-1)

Safety Data

• Safety Statements: 22-24/25
• WGK Germany: 3
• HazardClass: IRRITANT
• Hazardous Substances Data: 150256-42-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
FMOC-2-AMINOBENZOIC ACID is used as a building block for the synthesis of various pharmaceutical compounds. Its application is primarily due to its ability to protect the anthranilic acid moiety during the peptide synthesis process, which is crucial for the development of new drugs and therapeutic agents.
Used in Agrochemical Industry:
FMOC-2-AMINOBENZOIC ACID is used as a key intermediate in the production of agrochemicals, such as pesticides and herbicides. Its role in this industry is to contribute to the development of more effective and environmentally friendly products for agricultural use.
Used in Dyestuff Industry:
FMOC-2-AMINOBENZOIC ACID is used as a starting material for the synthesis of various dyes and pigments. Its application in this industry is due to its ability to provide a stable and versatile platform for the creation of a wide range of colorants for various applications, including textiles, plastics, and printing inks.

InChI:InChI=1/C22H17NO4/c24-21(25)18-11-5-6-12-20(18)23-22(26)27-13-19-16-9-3-1-7-14(16)15-8-2-4-10-17(15)19/h1-12,19H,13H2,(H,23,26)(H,24,25)/p-1

Upstream product

• 28920-43-6 (fluorenylmethoxy)carbonyl chloride 
• 118-92-3 anthranilic acid 
• 82911-69-1 N-(9H-fluoren-2-ylmethoxycarbonyloxy)succinimide 

Relevant articles and documents

Expanding the myxochelin natural product family by nicotinic acid containing congeners

Myxobacteria represent a viable source of chemically diverse and biologically active secondary metabolites. The myxochelins are a well-studied family of catecholate-type siderophores produced by various myxobacterial strains. Here, we report the discovery

Solid-Phase Total Synthesis of Dehydrotryptophan-Bearing Cyclic Peptides Tunicyclin B, Sclerotide A, CDA3a, and CDA4a using a Protected β-Hydroxytryptophan Building Block

A new approach to the synthesis of Z-dehydrotryptophan (ΔTrp) peptides is described. This approach uses Fmoc-β-HOTrp(Boc)(TBS)-OH as a building block, which is readily prepared in high yield and incorporated into peptides using solid-phase Fmoc chemistry. The tert-butyldimethylsilyl-protected indolic alcohol is eliminated during global deprotection/resin cleavage to give ΔTrp peptides exclusively as the thermodynamically favored Z isomer. This approach was applied to the solid-phase synthesis of tunicyclin B, sclerotide A, CDA3a, and CDA4a.

Discovery of Novel Nonpeptidic PAR2 Ligands

Proteinase-activated receptor 2 (PAR2) is a class A G protein-coupled receptor whose activation has been associated with inflammatory diseases and cancer, thus representing a valuable therapeutic target. Pathophysiological roles of PAR2 are often characterized using peptidic PAR2 agonists. Peptidic ligands are frequently unstable in vivo and show poor bioavailability, and only a few approaches toward drug-like nonpeptidic PAR2 ligands have been described. The herein-described ligand 5a (IK187) is a nonpeptidic PAR2 agonist with submicromolar potency in a functional assay reflecting G protein activation. The ligand also showed substantial β-arrestin recruitment. The development of the compound was guided by the crystal structure of PAR2, when the C-terminal end of peptidic agonists was replaced by a small molecule based on a disubstituted phenylene scaffold. IK187 shows preferable metabolic stability and may serve as a lead compound for the development of nonpeptidic drugs addressing PAR2.

Synthesis, biological evaluation, and docking studies of PAR2-AP-derived pseudopeptides as inhibitors of kallikrein 5 and 6

A series of protease activated receptor 2 activating peptide (PAR2-AP) derivatives (1-15) were designed and synthesized. The obtained compounds were tested on a panel of human kallikreins (hKLK1, hKLK2, hKLK5, hKLK6, and hKLK7) and were found completely i

Quinazolinones

Quinazolinones of formula (I) in which R, R1, R2, R3, R4, Y, n and m have the meaning indicated in Patent claim 1, and their salts or solvates as glycoprotein IbIX antagonists

Quinazolinones

Quinazolinones of formula (I) in which R, R1, R2, R3, R4, Y, Z, and m have the meaning indicated in patent claim 1, and their salts or solvates as glycoprotein IbIX antagonists.